recombinant 70-kD heat-shock protein

BIOLOGICAL2 trials

Sponsors

Memorial Sloan Kettering Cancer Center, UConn Health

Conditions

LeukemiaMelanoma (Skin)

Phase 1

Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia

CompletedNCT00030303

UConn HealthLeukemia

Start: 2001-01-31End: 2004-01-31Updated: 2017-04-28

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

CompletedNCT00005633

Memorial Sloan Kettering Cancer CenterMelanoma (Skin)

Start: 1999-06-30End: 2002-06-30Updated: 2013-06-19